Correlation between SARS‐COV‐2 antibody screening by immunoassay and neutralizing antibody testing
Transfusion2021Vol. 61(4), pp. 1181–1190
Citations Over TimeTop 10% of 2021 papers
Alfredo Mendrone, Carla Luana Dinardo, Suzete C. Ferreira, Anna Shoko Nishya, Nanci A. Salles, Cesar de Almeida‐Neto, Debora Toshei Hamasaki, Tila Facincani, Lucas Bassolli de Oliveira Alves, Rafael Rahal Guaragna Machado, Danielle Bastos Araújo, Edison Luíz Durigon, Vanderson Rocha, Éster Cerdeira Sabino
Abstract
SARS-CoV-2 IgG immunoassays (S/CO) can be used to predict high anti-SARS-CoV-2 nAbs titers. This study has proposed different criteria for identifying donors with ≥1:160 nAbs titers, all with high efficacy.
Related Papers
- → COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study(2020)53 cited
- → A possible dose‐response equation: Viral load after plasma infusion in COVID‐19 patients and anti‐SARS‐CoV‐2 antibody titers in convalescent plasma(2022)1 cited
- → Correlation between canine distemper and measles virus neutralizing capacities in human sera(1959)13 cited
- Distribution and persistence of neutralizing antibody titer against human cytomegalovirus in plasma donors in Sichuan Province,China(2012)
- → Investigation of SARS-CoV-2 RNAemia in the convalescent plasma of COVID-19 patients(2022)